Morphic Holding stock was surging Monday after pharmaceutical giant Eli Lilly agreed to acquire the biopharmaceutical company in a $3.2 billion deal. Lilly has agreed to pay $57 a share for ...

Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the ...

Eli Lilly is selling bonds to fund the acquisition of drug developer Morphic. The sale is reportedly ... unicorn” and upgraded its shares to a buy rating. The bump was based in part on sales ...

Eli Lilly is acquisitive, too, and just purchased a company called Morphic Holding ... Eli Lilly looks like a great stock to buy and hold for the long run, while its top-notch track record ...

Eli Lilly’s Morphic acquisition brings an oral small ... Eli Lilly is paying $140 million for the exclusive right to buy Radionetics Oncology for the price of $1 billion. The clinical-stage ...

The maintained Buy rating and price target signal confidence in Eli Lilly's continued growth and ... The company has also completed the acquisition of Morphic Holding (NASDAQ:MORF), Inc., adding ...

We recently published a list of 10 Stocks That May Be Splitting Soon. In this article, we are going to take a look at where ...

Eli Lilly(NYSE:LLY) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights ...

Morphic's lead ... the third quarter of 2024. Eli Lilly has a Zacks Rank #3 (Hold) currently. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The maintained Buy rating and price target signal confidence in Eli Lilly's continued growth and its ability to ... The company has also completed the acquisition of Morphic Holding (NASDAQ:MORF), Inc ...